New anti-pulmonary fibrosis prenylflavonoid glycosides from Epimedium koreanum

被引:12
|
作者
Zhao Yu-Dan [1 ]
Zhang Xin [1 ]
Yang Wan-Yue [1 ]
Zhang Rui-Qi [1 ]
Mu Lin-Tong [1 ]
Han Ling [3 ]
Lv Chong-Ning [1 ,2 ]
Lu Jin-Cai [1 ,2 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Shenyang 110016, Peoples R China
[2] Shenyang Pharmaceut Univ, Liaoning Prov Key Lab TCM Resources Conservat & D, Shenyang 110016, Peoples R China
[3] NERC Pharmaceut Tradit Chinese Med, Benxi 117004, Peoples R China
基金
中国国家自然科学基金;
关键词
Epimedium koreanum; Prenylflavonoid glycoside; Anti-pulmonary fibrosis; PRENYLATED FLAVONOL GLYCOSIDES; CONSTITUENTS; ICARIIN;
D O I
10.1016/S1875-5364(21)60116-4
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Four new prenylflavonoid glycosides, namely koreanoside H-K (1-4), together with eleven known ones (5-15) were isolated from the leaves of Epimedium koreanum Nakai. Their structures were elucidated by 1D NMR, 2D NMR, HR-ESI-MS, IR and UV. The identification of the sugar moieties was carried out by means of acid hydrolysis and HPLC analysis of their derivatives. It is worth noting that compound 3 and compound 4 were elucidated to contain fucose and quinovose moieties, which were two extremely rare sugar units from the genus Epimedium. The anti-pulmonary fibrosis activity of the new compounds was evaluated using A549 cell line. Compounds 1, 2 and 4 showed significant anti-pulmonary fibrosis activities.
引用
下载
收藏
页码:221 / 228
页数:8
相关论文
共 50 条
  • [21] Comprehensive review of potential drugs with anti-pulmonary fibrosis properties
    Ma, Jie
    Li, Gang
    Wang, Han
    Mo, Chunheng
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 173
  • [22] A new flavonol glycoside from the aerial parts of Epimedium koreanum Nakai
    Han, Fubo
    Lee, Ik-Soo
    NATURAL PRODUCT RESEARCH, 2017, 31 (03) : 320 - 325
  • [23] Effects of total flavonoids and flavonol glycosides from Epimedium koreanum Nakai on the proliferation and differentiation of primary osteoblasts
    Zhang, D. -W.
    Cheng, Y.
    Wang, N. -L.
    Zhang, J. -C.
    Yang, M. -S.
    Yao, X. -S.
    PHYTOMEDICINE, 2008, 15 (1-2) : 55 - 61
  • [24] Component analysis and anti-pulmonary fibrosis effects of Rosa sterilis juice
    Wang, Liqun
    Li, Yali
    Xia, Rui
    Zheng, Xinyue
    Li, Xingjie
    Wu, Shouxun
    Zhang, Qianyu
    Li, Sha
    Deng, Yuanle
    Yao, Yuqin
    Ye, Tinghong
    Yin, Wenya
    FOOD & FUNCTION, 2022, 13 (24) : 12915 - 12924
  • [25] The anti-pulmonary fibrosis activity of Osmanthus fragrans and its major compound
    Ye, Y-L
    Shi, L-S
    Wu, Y-Y
    ALLERGY, 2013, 68 : 63 - 63
  • [26] Repurposing of Pirfenidone (Anti-Pulmonary Fibrosis Drug) for Treatment of Rheumatoid Arthritis
    Gan, Donghao
    Cheng, Wenxiang
    Ke, Liqing
    Sun, Antonia RuJia
    Jia, Qingyun
    Chen, Jianhai
    Lin, Jietao
    Li, Jian
    Xu, Zhanwang
    Zhang, Peng
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [27] PPAR-y mediates the anti-pulmonary fibrosis effect of icaritin
    Hua, Qingzhong
    Huang, Xiaoting
    Xie, Weixi
    Zhao, Feiyan
    Cheng, Haipeng
    Luo, Ziqiang
    Han, Jianzhong
    Wang, Zun
    Zeng, Qian
    Lin, Miao
    Zhou, Tingting
    Zhang, Jialu
    Gu, Can
    Liu, Wei
    Tang, Siyuan
    TOXICOLOGY LETTERS, 2021, 350 : 81 - 90
  • [28] A NEW FLAVONOL GLYCOSIDE CAOHUOSIDE-D FROM EPIMEDIUM KOREANUM NAKAI
    Wen Kui LI
    Pei Gen XIAO(Institute of Medicinal Plant Development.Chinese Academy of Medicat Sciences and Peking Union Medical College
    Chinese Chemical Letters, 1994, (11) : 945 - 946
  • [29] 8-(3,3-dimethylallyl)-substituted flavonoid glycosides from the aerial parts of Epimedium koreanum
    Zhao, Hai-Yu
    Fan, Li
    Zhou, Lei
    Han, Jian
    Wang, Rao-Rong
    Guo, De-An
    HELVETICA CHIMICA ACTA, 2007, 90 (11) : 2186 - 2195
  • [30] Steroidal saponins and homoisoflavonoids from the fibrous roots of ophiopogon japonicus and their anti-pulmonary fibrosis activities
    Pu, Hang-Yi
    Cao, Yu
    Jiang, Xi-Lang
    Yang, Lin-Han
    Wang, Ming-Kui
    Wang, Fei
    Wang, Lun
    NATURAL PRODUCT RESEARCH, 2024,